TAK-834-4008: Quantitative Testing of Patient and Healthcare Provider Knowledge, Attitudes, and Behavior About NATPARA® (Parathyroid Hormone) for Injection, for Subcutaneous Use (NATPARA KAB) First published 26/09/2022 Last updated 07/01/2025 EU PAS number:EUPAS48713 Study Ongoing